SRSD-107

N/A

Report date: 2026/04/30 20:00:20
NMEFirst In Class

Base Information

Drug NameSRSD-107
Drug Alias NameSRSD107SRSD-107
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceCoagulation factor XI inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsArterial ThromboembolismThrombosisVenous Thromboembolism +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSirius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSirius Therapeutics Co LtdSirius Therapeutics IncCrispr Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsArterial ThromboembolismThrombosisVenous Thromboembolism +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A